title: [Clinical observation of jianpi bushen formula to prevent collapse of osteonecrosis of femoral head].
abstract: To observe the clinical effect of Jianpi Bushen formula to prevent the collapse of osteonecrosis of femoral head (ONFH) of type phlegm and blood stasis obstructing the collaterals. 50 cases (including 73 hips) of non-collapse ONFH (ARCO I, II, III a) were selected from the out-patient department of orthopedic in Guang'anmen Hospital attached to China Academy of Chinese Medical Science. All the cases fit for diagnostic criteria were given Jianpi Bushen formula and followed up. Staging criteria was ARCO classification. Harris score evaluated the hip function. The mean follow-up time was 4.2 years (3-5.4 years). After a mean of 4.2 years (3-5.4 years) followed-up, 12 hips collapse occurred while 61 hips not (the non-collapse rate was 83.56%). Collapse did not occurred among the all 7 hips at stage ARCO I (the non-collapse rate was 100%). Among the 49 hips at stage ARCO II, 9 hips collapse occurred while 40 hips not (the non-collapse rate was 81.63%). Among the 17 hips at stage ARCO III a, 3 hips collapse occurred while 14 hips not (the non-collapse rate was 82.35%). Kaplan-Meier analysis showed the average survival time of non-collapse was 5 years (4. 8-5.2 years). The 3 year survival rate of non-collapse was 92.5%. The 4 year survival rate was 74% and the condition tended to be stability trend. The Harris score was 71.93 +/- 11.25 before treatment and 81.63 +/- 12.16 after treatment, significantly different. These results suggest that: Jianpi Bushen formula is an effective method for treating ONFH of type phlegm and blood stasis obstructing the collaterals. It can delay or prevent the collapse of femoral head and significantly improve the hip function.
authors.affiliation: Guang'anmen Hospital, China Academy of Traditional Chinese Medicine, Beijing 100053, China.
authors.forename: Tong
authors.initials: T
authors.lastname: Yu
authors.forename: Li-Min
authors.initials: LM
authors.lastname: Xie
authors.forename: Wen-Yue
authors.initials: WY
authors.lastname: Wang
authors.forename: Ying-Peng
authors.initials: YP
authors.lastname: Xu
authors.forename: Yu-Bin
authors.initials: YB
authors.lastname: Li
authors.forename: Zhen-Nan
authors.initials: ZN
authors.lastname: Zhang
authors.forename: Liang
authors.initials: L
authors.lastname: Han
authors.forename: Lin-Xi
authors.initials: LX
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D005271:Femur Head Necrosis / Q000188:drug therapy* / Q000517:prevention & control; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal